Franklin Resources
RIGL icon

Franklin Resources’s Rigel Pharmaceuticals RIGL Stock Holding History

Franklin Resources’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.83M Buy
123,364
+9,486
+8% +$293K ﹤0.01% 1622
2026
Q1 		$3.08M Buy
113,878
+72,855
+178% +$2.45M ﹤0.01% 1736
2025
Q4 		$1.76M Buy
41,023
+4,430
+12% +$167K ﹤0.01% 1851
2025
Q3 		$1.04M Buy
36,593
+12,220
+50% +$366K ﹤0.01% 2080
2025
Q2 		$457K Buy
24,373
+135
+0.6% +$2.56K ﹤0.01% 2361
2025
Q1 		$436K Buy
24,238
+2,429
+11% +$49.3K ﹤0.01% 2323
2024
Q4 		$367K Buy
21,809
+9,043
+71% +$173K ﹤0.01% 2431
2024
Q3 		$193K Buy
+12,766
New +$150K ﹤0.01% 2646
2024
Q2 		– Sell
-7,006
Closed -$104K – 2955
2024
Q1 		$104K Hold
7,006
– – ﹤0.01% 2706
2023
Q4 		$102K Hold
7,006
– – ﹤0.01% 2468
2023
Q3 		$75.7K Sell
7,006
-11,062
-61% -$133K ﹤0.01% 2488
2023
Q2 		$233K Buy
18,068
+12,373
+217% +$167K ﹤0.01% 2314
2023
Q1 		$75.2K Sell
5,695
-379
-6% -$6.02K ﹤0.01% 2145
2022
Q4 		$91.1K Buy
6,074
+169
+3% +$1.55K ﹤0.01% 2139
2022
Q3 		$69K Buy
5,905
+54
+0.9% +$730 ﹤0.01% 2163
2022
Q2 		$66K Sell
5,851
-2,734
-32% -$54.9K ﹤0.01% 2208
2022
Q1 		$257K Buy
8,585
+419
+5% +$11.3K ﹤0.01% 2077
2021
Q4 		$216K Buy
8,166
+6,768
+484% +$204K ﹤0.01% 2209
2021
Q3 		$50K Buy
1,398
+150
+12% +$5.9K ﹤0.01% 2379
2021
Q2 		$54K Buy
+1,248
New +$47.1K ﹤0.01% 1951

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's RIGL Position: Q2 2026 in Review

Franklin Resources increased its Rigel Pharmaceuticals (RIGL) stake by 8.3% in Q2 2026, buying an estimated $293K and bringing the position to 123,364 shares worth $4.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Franklin Resources first reported a position in RIGL in Q2 2021 and has held it in 20 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Franklin Resources held 123,364 shares of Rigel Pharmaceuticals worth $4.83M as of Q2 2026.
  • Franklin Resources bought 9,486 Rigel Pharmaceuticals shares in Q2 2026, an estimated $293K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1622 holding.
  • Franklin Resources first reported a position in Rigel Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.